Several studies have demonstrated the importance of achieving the American Diabetes Association (ADA) clinical guidelines in adults. However, research is limited on adherence to these guidelines in the pediatric population. This retrospective chart review examined 56 charts from 6 physician offices and 1 multispecialty health care system in Ohio. Variables of interest included recommendations from the 2007 ADA Standards of Medical Care in Diabetes. HgA1c was measured every 3 months in 44.6% of patients, while 55% achieved A1c goal. Blood pressure was monitored in all patients, with 57% meeting goal. Lipids and urine microalbumin were tested annually in 51.7% and 26.7% of patients, respectively. Dilated eye and foot exams were performed on 53.5% and 37.5% of patients, respectively. Adherence to ADA clinical guidelines for pediatric patients with type 2 diabetes is suboptimal. The authors recommend that specific evidence-based guidelines be evaluated for children with type 2 diabetes.
American Diabetes Association.Type 2 diabetes in children and adolescents . Diabetes Care. 2000;23: 381-389.
2.
The International Diabetes Federation Consensus Workshop.Type 2 diabetes in the young: the evolving epidemic . Diabetes Care. 2004;27:1798-1811.
3.
Kaufman FRType 2 diabetes mellitus in children and youth: a new epidemic. J Pediatr Endocrinol Metabol. 2002;15(suppl 2):737-744.
4.
The Writing Group for the SEARCH for Diabetes in Youth Study Group.Incidence of diabetes in youth in the United States. JAMA. 2007;297:2716-2724.
5.
Matyka KAType 2 diabetes in childhood: epidemiological and clinical aspects. Br Med Bull. 2008;86:59-75.
6.
American Diabetes Association.Standards of medical care in diabetes: 2007. Diabetes Care . 2007;30:S4-S41.
7.
Reinehr T., Schober E., Roth C., Wiegand S., Holl R.Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res. 2008 ;69:107-113.
8.
Kershnar AK, Daniels SR, Imperatore G., et al. Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the search for diabetes in youth study. J Pediatr . 2006;114:217-223.
9.
American Diabetes Association.Type 2 diabetes in children and adolescents (consensus statement). Diabetes Care. 2000 ;23:381-389.
10.
American Diabetes Assocaition.Management of dyslipidemia in children and adolescents with diabetes (consensus statement). Diabetes Care. 2003;26:2194-2197.
11.
UK Prospective Diabetes Study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
12.
The Diabetes Control and Complications Trial Research Group.The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
13.
Peterson K. , Silverstein J., Kaufman F., Warren-Boulton E.Management of type 2 diabetes in youth: an update. Am Fam Physician. 2007;76:658-664,665-666.
14.
Saaddine JB , Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KMA diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-574.
15.
Saydah SH, Fradkin J., Cowie CCPoor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
16.
McGill HC Jr, McMahanCA. Determinants of atherosclerosis in the young: Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am J Cardiol . 1998;82:30T-36T.
17.
Petitti DB, Imperatore G., Palla SL, et al. Serum lipids and glucose control: the SEARCH for diabetes in youth study. Arch Pediatr Adolesc Med. 2007 ;161:159-165.
18.
Cheung BM, Ong KL, Cherny SS, Sham PC, Tso AW, Lam KSDiabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. Am J Med. 2009;122:443-453.
19.
National High Blood Pressure Education Program Working Group on High Blood Pressure in Children.The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics. 2004 ;114(2 suppl):555-576.
20.
Gerstein HC , Mann JF, Yi Q., et al; HOPE Study Investigators.Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA . 2001;286:421-426.
21.
Ettinger LM , Freeman K., DiMartino-Nardi JR, Flynn JTMicroalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr. 2005;147:67-73.
22.
Krakoff J., Lindsay RS, Looker HC, Nelson RG, Hanson RL, Knowler WCIncidence of retinopathy and nephropathy in youth-onset compared with adult-onset type 2 diabetes. Diabetes Care. 2003;26:76-81.
23.
Eppens MC, Craig ME, Cusumano J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care. 2006;29: 1300-1306.
24.
Pitteloud N. , Mootha VK, Dwyer AA, et al. Relationship between testosterone levels, insulin sensitivity, and mitochondrial function in men. Diabetes Care. 2005;28: 1636-1642.
25.
Godsland IF , Walton C., Felton C., Proudler A., Patel A., Wynn V.Insulin resistance, secretion, and metabolism in users of oral contraceptives. J Clin Endocrinol Metab. 1992;74: 64-70.
26.
Kennedy M.Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence . Clin Pharmacol Ther. 2008;84:662-673.
27.
Rocchini AP , Katch V., Kveselis D., et al. Insulin and renal sodium retention in obese adolescents. Hypertension. 1989;14:367-374.
28.
Rocchini AP , Key J., Bondie D., et al. The effect of weight loss on the sensitivity of sodium in obese adolescents. N Engl J Med. 1989;321:580-585.
29.
Zeitler P., Epstein L., Grey M., et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes . Pediatr Diabetes. 2007;8:74-87.
30.
Gottschalk M., Danne T., Vlajnic A., Cara JFGlimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes. Diabetes Care . 2007;30:790-794.
31.
Kavey RE, Allada V., Daniels SR, et al; American Heart Association Expert Panel on Population and Prevention Science; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Epidemiology and Prevention; American Heart Association Council on Nutrition, Physical Activity and Metabolism; American Heart Association Council on High Blood Pressure Research; American Heart Association Council on Cardiovascular Nursing; American Heart Association Council on the Kidney in Heart Disease; Interdisciplinary Working Group on Quality of Care and Outcomes Research. Cardiovascular risk reduction in high-risk pediatric patients: a scientific statement from the American Heart Association Expert Panel on Population and Prevention Science; the Councils on Cardiovascular Disease in the Young, Epidemiology and Prevention, Nutrition, Physical Activity and Metabolism, High Blood Pressure Research, Cardiovascular Nursing, and the Kidney in Heart Disease; and the Interdisciplinary Working Group on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics . Circulation. 2006;114:2710-2738.
32.
Dabelea D., Bell RA, D’Agostino RB Jr , et al. Incidence of diabetes in youth in the United States . JAMA. 2007; 297:2716-2724.
33.
Reinehr T., Schober E., Wiegand S., Thon A., Holl R.Beta-cell autoantibodies in children with type 2 diabetes mellitus: subgroup or misclassification? Arch Dis Child. 2006 ; 91:473-477.
34.
Purushothaman R., Ramchandani N., Kazachkova I., Ten S.Prevalence and clinical features of type 1.5 diabetes mellitus in children. J Pediatr Endocrinol Metab . 2007; 20:981-987.
35.
Ditmyer MM, Price JH, Telljohann SK, Rogalski F.Pediatricians’ perceptions and practices regarding prevention and treatment of type 2 diabetes mellitus in children and adolescents. Arch Pediatr Adolesc Med. 2003;157:913-918.
36.
DCCT Research Group.Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin dependent diabetes mellitus: Diabetes Control and Complications Trial. J Pediatr. 1994;125:177-188.
